对脱发患者的低剂量口服米诺西迪尔启动:国际修改的德尔菲共识声明
Yagiz Matthew Akiska1, Paradi Mirmirani2, Ingrid Roseborough3
1George Washington University School of Medicine & Health Sciences, Washington, DC.
JAMA dermatology
|November 20, 2024
概括
低剂量口服氧化 (LDOM) 显示在脱发治疗中具有前景. 这份专家共识提供了关于其在成人和青少年的非标签使用的指导,等待进一步的研究.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
- 修复头发科学 修复头发科学
背景情况:
- 小规模研究表明,低剂量口服氧化 (LDOM) 是一种安全有效的脱发治疗方法.
- 目前缺乏标准化指导方针和大规模试验,用于脱发中的LDOM.
研究的目的:
- 为了建立一个国际专家共识声明,为患有脱发的患者开处方低剂量口服氧化 (LDOM).
主要方法:
- 对LDOM在脱发中的药理学,安全性和疗效进行了全面的文献审查.
- 一个经过修改的Delphi共识过程涉及43名国际脱发专家,进行了四轮调查.
- 共识被定义为在76项5分利克特等级上至少70%的同意.
主要成果:
- 在LDOM的适用情况,与局部米诺克西迪尔的比较,成人和青少年剂量,禁忌,预防措施,基线评估,监测和辅助疗法方面达成了共识.
- 缺乏共识的领域包括儿科使用和剂量 (12岁以下儿童) 以及特定的LDOM定位协议.
结论:
- 这份共识声明为临床医生提供了实用指导,用于治疗成人和青少年脱发的非标签LDOM.
- 需要进一步的研究,特别是关于儿科LDOM的使用,与局部米诺克西迪尔的比较疗效和长期安全性.
- 随着更多基于证据的数据变得可用,建议将被更新.
相关概念视频
Antihypertensive Drugs: Vasodilators
479
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
479
Rational Dosage Regimen: Maintenance Dose and Loading Dose
3.9K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
3.9K


